Cite
Development of doxorubicin hydrochloride-loaded whey protein nanoparticles and its surface modification with N-acetyl cysteine for triple-negative breast cancer.
MLA
Singh, Samipta, et al. “Development of Doxorubicin Hydrochloride-Loaded Whey Protein Nanoparticles and Its Surface Modification with N-Acetyl Cysteine for Triple-Negative Breast Cancer.” Drug Delivery and Translational Research, vol. 12, no. 12, Dec. 2022, pp. 3047–62. EBSCOhost, https://doi.org/10.1007/s13346-022-01169-8.
APA
Singh, S., Maurya, P., Rani, S., Mishra, N., Nisha, R., Singh, P., & Saraf, S. A. (2022). Development of doxorubicin hydrochloride-loaded whey protein nanoparticles and its surface modification with N-acetyl cysteine for triple-negative breast cancer. Drug Delivery and Translational Research, 12(12), 3047–3062. https://doi.org/10.1007/s13346-022-01169-8
Chicago
Singh, Samipta, Priyanka Maurya, Soniya Rani, Nidhi Mishra, Raquibun Nisha, Priya Singh, and Shubhini A Saraf. 2022. “Development of Doxorubicin Hydrochloride-Loaded Whey Protein Nanoparticles and Its Surface Modification with N-Acetyl Cysteine for Triple-Negative Breast Cancer.” Drug Delivery and Translational Research 12 (12): 3047–62. doi:10.1007/s13346-022-01169-8.